SOCS1 and cancer: The methylation status of SOCS1 and SOCS3 are evaluated in different cancers e.g., ovarian and breast carcinomas, Barrett’s adenocarcinoma, gastrointestinal cancers like hepatocellular carcinoma, pancreatic carcinoma, human lung, and head and neck cancer [28, 29].